Completed Brain & Nervous System Genetics & Molecular Biology

Transcriptional control of CNS myelination in development and maturity.

In plain English

AI plain-English summary

The brain continues to manufacture new myelin—the fatty insulation around nerve fibres—well into adulthood, and this project aims to discover the genetic switches that control that process. Most myelin-making cells, called oligodendrocytes, form shortly after birth, but fresh ones keep appearing throughout healthy adult life, possibly helping with learning and memory. These cells arise from precursor cells that can also turn into other brain cell types. Understanding the genetic mechanisms that govern this production line could open routes to treatments for demyelinating diseases such as multiple sclerosis, where the loss of myelin disrupts nerve signalling. The researchers will focus on a family of proteins called Olig transcription factors, which act as master regulators of oligodendrocyte development. They will use genetically modified mice to watch new myelin being made in real time, and will map how chemical modifications to Olig proteins alter their behaviour and target genes. They will also identify the signalling pathways that trigger these modifications. This is fundamental science. If successful, it will provide a detailed molecular blueprint for generating oligodendrocytes from stem cells in the lab—a step toward cell-replacement therapies for demyelinating disease. Similar fundamental work on transcription factors has already enabled the direct reprogramming of skin cells into neurons.

View original technical description
Most oligodendrocytes (OLs) are formed in the early postnatal period but myelin-forming OLs continue to be born throughout healthy adult life, possibly contributing to learning and memory. New OLs are generated from proliferating oligodendrocyte precursors (OPs), which can also generate astrocytes and perhaps even neurons in some contexts. If we could understand the genetic mechanisms that control production of OPs and their differentiated progeny, we could use this knowledge to devise treatme nts for demyelinating and other neurodegenerative diseases. Towards this goal, we will investigate the transcriptional control of OP production and OL lineage progression during development and maturity. Our focus will be the Olig transcription factors, their post-transcriptional modifications and their modification-dependent activities and targets. We will also study myelin dynamics and its regulation during adulthood. Our aims are: A) to use mouse transgenesis to visualize adult myelin genesis and to gain clues to its regulation and functions. B) to determine how phosphorylation of Olig proteins alters their interactions with co-factors and gene targets and, by introducing Olig mutations into mice, how this orchestrates OL lineage progression during development and adulthood. C) to identify the signaling pathways that target Olig phosphorylation. D) to use this information to streamline OP production from induced pluripotent stem cells or somatic cells, for potential clinical application in the longer term.

View the original record at the funder ↗

Researchers

William Richardson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Adaptive myelination in learning and memory
Control of oligodendrocyte development by olig2 and chromatin remodelling complexes
Mechanisms of Myelination – Elucidating the Diversity of Oligodendroglial Precursors and their Local Axon-Glia Interactions
Determinants of oligodendrocyte cell fate in development and disease.
Myelin at the crossroads of Development and Disease

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.